Hind Rectifiers Intrinsic Value
HIRECT • Capital Goods
Current Stock Price
₹693.25
Primary Intrinsic Value
₹411.84
Market Cap
₹208.0 Cr
-7.4%
Downside
Median Value
₹641.75
Value Range
₹220 - ₹1387
Assessment
Trading Near Calculated Value
Safety Margin
-8.0%
HIRECT Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹411.84 | ₹329.47 - ₹494.21 | -40.6% | EPS: ₹34.32, Sector P/E: 12x |
| Book Value Method | asset | ₹533.33 | ₹480.00 - ₹586.66 | -23.1% | Book Value/Share: ₹533.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1386.50 | ₹1247.85 - ₹1525.15 | +100.0% | Revenue/Share: ₹3026.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1386.50 | ₹1247.85 - ₹1525.15 | +100.0% | EBITDA: ₹104.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1153.01 | ₹922.41 - ₹1383.61 | +66.3% | CF Growth: 5.9%, Discount: 15% |
| PEG Ratio Method | growth | ₹219.65 | ₹197.69 - ₹241.62 | -68.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹282.80 | ₹254.52 - ₹311.08 | -59.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1386.50 | ₹1247.85 - ₹1525.15 | +100.0% | ROE: 37.5%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹641.75 | ₹577.58 - ₹705.93 | -7.4% | EPS: ₹34.32, BVPS: ₹533.33 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
HIRECT Intrinsic Value Analysis
What is the intrinsic value of HIRECT?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Hind Rectifiers (HIRECT) is ₹641.75 (median value). With the current market price of ₹693.25, this represents a -7.4% variance from our estimated fair value.
The valuation range spans from ₹219.65 to ₹1386.50, indicating ₹219.65 - ₹1386.50.
Is HIRECT undervalued or overvalued?
Based on our multi-method analysis, Hind Rectifiers (HIRECT) appears to be trading near calculated value by approximately 7.4%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 6.77 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 37.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.18x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Hind Rectifiers
Additional stock information and data for HIRECT
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹36 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹34 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |